Cargando…

Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease

Many genetic risk factors for Parkinson’s disease have lipid-related functions and lipid-modulating drugs such as statins may be protective against Parkinson’s disease. Moreover, the hallmark Parkinson’s disease pathological protein, α-synuclein, has lipid membrane function and pathways dysregulated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galper, Jasmin, Dean, Nicholas J, Pickford, Russell, Lewis, Simon J G, Halliday, Glenda M, Kim, Woojin S, Dzamko, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586542/ https://www.ncbi.nlm.nih.gov/pubmed/35551349 http://dx.doi.org/10.1093/brain/awac176

Ejemplares similares

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
por: Galper, Jasmin, et al.
Publicado: (2022)

Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
por: Youssef, Priscilla, et al.
Publicado: (2021)

Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain
por: Fu, YuHong, et al.
Publicado: (2022)

Sex-specific lipid dysregulation in the Abca7 knockout mouse brain
por: Fu, YuHong, et al.
Publicado: (2022)

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
por: Atashrazm, Farzaneh, et al.
Publicado: (2018)

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
por: Youssef, Priscilla, et al.
Publicado: (2023)

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
por: Phan, Katherine, et al.
Publicado: (2022)

Parkinson’s progression prediction using machine learning and serum cytokines
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2019)

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
por: Dzamko, Nicolas, et al.
Publicado: (2014)

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease
por: Galper, Jasmin, et al.
Publicado: (2021)

Lipid dysfunction and pathogenesis of multiple system atrophy
por: Bleasel, Jonathan M, et al.
Publicado: (2014)

Uncovering pathophysiological changes in frontotemporal dementia using serum lipids
por: Phan, Katherine, et al.
Publicado: (2020)

Glucocerebrosidase Activity is Reduced in Cryopreserved Parkinson’s Disease Patient Monocytes and Inversely Correlates with Motor Severity
por: Hughes, Laura P., et al.
Publicado: (2021)

Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
por: Cheng, Danni, et al.
Publicado: (2011)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia
por: He, Ying, et al.
Publicado: (2021)

Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy
por: Don, Anthony S, et al.
Publicado: (2014)

Exploring Myelin Dysfunction in Multiple System Atrophy
por: Wong, Joanna H., et al.
Publicado: (2014)

Toll-like receptor 2 is increased in neurons in Parkinson’s disease brain and may contribute to alpha-synuclein pathology
por: Dzamko, Nicolas, et al.
Publicado: (2016)

A small molecule toll-like receptor antagonist rescues α-synuclein fibril pathology
por: Chedid, Jessica, et al.
Publicado: (2022)

Cytokine activity in Parkinson’s disease
por: Dzamko, Nicolas
Publicado: (2023)

Investigating lymphocyte populations in patients with Parkinson’s disease
por: Dzamko, Nicolas
Publicado: (2020)

Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development
por: Kim, Woojin Scott, et al.
Publicado: (2018)

Mannose 6-Phosphate Receptor Is Reduced in -Synuclein Overexpressing Models of Parkinsons Disease
por: Matrone, Carmela, et al.
Publicado: (2016)

LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm, Farzaneh, et al.
Publicado: (2016)

PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
por: Li, Wen, et al.
Publicado: (2021)

Editorial: Updates on inflammation in Parkinson's disease
por: Dzamko, Nicolas, et al.
Publicado: (2023)

Role of the Long Non-Coding RNA MAPT-AS1 in Regulation of Microtubule Associated Protein Tau (MAPT) Expression in Parkinson's Disease
por: Coupland, Kirsten G., et al.
Publicado: (2016)

Aspects of Innate Immunity and Parkinson’s Disease
por: Huang, Yue, et al.
Publicado: (2012)

Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker
por: Perera, G., et al.
Publicado: (2016)

Alpha-synuclein biology in Lewy body diseases
por: Kim, Woojin Scott, et al.
Publicado: (2014)

Glycoprotein Pathways Altered in Frontotemporal Dementia With Autoimmune Disease
por: Bright, Fiona, et al.
Publicado: (2021)

Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers
por: Zhao, Ye, et al.
Publicado: (2018)

Animal modeling an oligodendrogliopathy – multiple system atrophy
por: Bleasel, Jonathan M., et al.
Publicado: (2016)

α-Synuclein Regulates Neuronal Cholesterol Efflux
por: Hsiao, Jen-Hsiang T., et al.
Publicado: (2017)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice
por: Zhao, Ye, et al.
Publicado: (2018)

Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
por: Ahmadi Rastegar, Diba, et al.
Publicado: (2022)

Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia
por: Phan, Katherine, et al.
Publicado: (2021)

Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
por: Gregersen, Emil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ttf4ifmrk6ft2c5h5cvq3j674s